MedPath
HSA Approval

WAMLOX FILM-COATED TABLETS 10MG/160MG

SIN16843P

WAMLOX FILM-COATED TABLETS 10MG/160MG

WAMLOX FILM-COATED TABLETS 10MG/160MG

August 22, 2023

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C09DB01

valsartan and amlodipine

Manufacturer Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

KRKA, d.d., Novo mesto

Active Ingredients

Valsartan

160.00mg

Valsartan

Amlodipine Besilate eqv. Amlodipine

10.00mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

WAMLOX FILM-COATED TABLETS 10MG/160MG - HSA Approval | MedPath